June 19, 2024
The birth prevalence of congenital hyperinsulinism: a narrative review of the epidemiology of a rare disease
October 09, 2023
NEJM Letter to the Editor: Anti–Insulin Receptor Antibody for Malignant Insulinoma and Refractory Hypoglycemia
November 30, 2021
Rezolute profiled in Nature’s BioPharma Dealmakers, Nature Biotechnology, and Nature Reviews Drug Discovery, November 2019 editions
November 30, 2021
Attenuation of Insulin Action by an Allosteric Insulin Receptor Antibody in Healthy Volunteers
November 30, 2021